Podcasts
Many people are familiar with MK-ULTRA, the CIA’s illegal human experimentation program, which involved psychedelics and resulted in torture techniques that have since been used at CIA black sites around the world. What if someone tried to tell you these techniques were, in fact, a novel therapy tha
Podcasts
Michael Pollan, Tim Ferriss, Gabor Maté, and a number of other “thought leaders” have offered glowing endorsements of Françoise Bourzat and her approach to training psychedelic guides. However, amidst the wave of allegations and revelations about Bourzat, her husband Aharon Grossbard, and their trai
Podcasts
The Psymposia team, discusses how the “Psychedelic Community” responded to T’s abuse of Lily in the Ecuadorian Amazon and her attempts to call attention to the wider issues around her experience. We recall our own experiences of Lily’s efforts dating back to 2012, and consider a number of individual
Podcasts
Power Tripping is Psymposia’s weekly deep-dive into New York Magazine’s Cover Story: Power Trip podcast, co-produced with Psymposia.
Podcasts
In part two of our conversation with Villanova visiting professor of philosophy Emma Stamm, we discuss the “psychedelic industry’s” increasing fixation on digital capitalism. Looking at apps like MyDelica and hardware like Kernel’s brain-scanning helmet, we discuss how the social implications of thi
Podcasts
In part one of our conversation with Villanova visiting professor of philosophy Emma Stamm, we discuss Mark Fisher’s Acid Communism, leftist thought in psychedelia, Jacques Derrida’s hauntology, and Byung-Chul Han’s Psychopolitics: Neoliberalism and New Technologies of Power.
Podcasts
In Part Two, the crew continues their break down of Atai Life Sciences’ founder and COMPASS Pathways investor Christian Angermayer’s recent appearance on right-wing YouTuber Dave Rubin’s “The Rubin Report.”
Podcasts
In Part One, the crew breaks down Atai Life Sciences’ founder and COMPASS Pathways investor Christian Angermayer’s recent appearance on right-wing YouTuber Dave Rubin’s “The Rubin Report.”
Podcasts
The crew reviews Michael Pollan’s recent New York Times Op-Ed “How Should We Do Drugs Now?”
Podcasts
In Part Two Normie, Dave, Russell, and Sarvesh continue their conversation about Atai Life Sciences and how the introduction of for-profit psychedelic pharmaceutical corporations have shifted capital away from non-profits. This episode gets extra wacky and dark as they dive into Atai Founder & Chair
Podcasts
Brian Normand, David Nickles, and Russell Hausfeld are joined by new team member, Sarvesh Ramprakash, to discuss Atai Life Sciences’ recent IPO on Nasdaq. They also discuss and provide updates on Russell’s previous 2020 report exploring how the introduction of for-profit psychedelic pharmaceutical c
Podcasts
In Part Two, the Psymposia crew continues to deconstruct a conversation between two self-described entrepreneurs who recently discussed psychedelics and medicalization during an event called Psychedelic Capitalism with Alexander Beiner [Rebel Wisdom] and Lars Wilde [COMPASS Pathways, Atai Life Scien